Your session is about to expire
← Back to Search
ZB131 for Solid Cancers
Study Summary
This trial is testing a new drug, ZB131, to see if it is safe and effective in treating solid tumors. Up to 24 patients will be enrolled, and the drug will be given via IV every week.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a type of cancer that starts in the brain.You have received a live vaccine in the last 6 weeks before starting the study drug.The study is looking for participants who have advanced or metastatic pancreatic, ovarian, or biliary cancer and have not responded to or are not eligible for standard treatment.You have advanced cancer that has not responded to standard treatment, and there are no other available treatments that can cure your cancer.You have severe digestive problems, such as a blocked intestine, within 4 weeks before the study.You need medication that reduces your immune system's activity.You cannot have received a COVID-19 vaccine within a week before the start of the study, and you cannot receive a vaccine or booster less than 3 weeks before a tumor assessment during the study.
- Group 1: Active Treatment: ZB131
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research project currently enrolling participants?
"Affirmative. Per clinicaltrials.gov, this medical trial is recruiting participants as of now; it was initially posted on January 14th 2022 and was most recently modified on August 31st 2022. 37 volunteers must be sought from 9 distinct study sites."
How many medical institutions are active participants in this research?
"Presently, the trial is recruiting at nine sites across America. Some of these include Mayo Clinic - Phoenix in Arizona, Mayo Clinic - Rochester in Minnesota and MD Anderson Cancer Centre located in Houston Texas."
What is the scope of enrolment for this research experiment?
"Affirmative. According to clinicaltrials.gov, recruitment for this study is currently underway - it was initially posted on 14th January 2022 and last modified on 31st August 2022. A total of 37 participants from 9 distinct medical sites are being sought after."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger